EUVIMEDEUVIMED entdecken
Open Access

Medication and Road Test Performance Among Cognitively Healthy Older Adults

David B Carr, Kebede Beyene, Jason Doherty, Samantha A Murphy, Ann M Johnson, Hailee Domash, Noah Riley, Alexis Walker, Ashwin Sabapathy, John C Morris, Ganesh M Babulal

JAMA Network Open · 2023

DOI: 10.1001/jamanetworkopen.2023.35651 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, 2023. Verfasst von David B Carr und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Washington University in St Louis, St Louis, Missouri. Hauptthemen laut MEDLINE: Antidepressive Agents, Cholinergic Antagonists. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Older adults are increasingly prescribed medications that have adverse effects. Prior studies have found a higher risk of motor vehicle crashes to be associated with certain medication use.

Objective

To determine whether specific medication classes were associated with performance decline as assessed by a standardized road test in a community sample of cognitively healthy older adults, to evaluate additional associations of poor road test performance with comorbid medical conditions and demographic characteristics, and to test the hypothesis that specific medication classes (ie, antidepressants, benzodiazepines, sedatives or hypnotics, anticholinergics, antihistamines, and nonsteroidal anti-inflammatory drugs or acetaminophen) would be associated with an increase in risk of impaired driving performance over time. Design, Setting, and Participants This was a prospective cohort study of 198 cognitively healthy adults 65 years and older with a valid driver’s license who were followed up annually, with rolling enrollment. Data were collected from participants in St Louis, Missouri, and neighboring Illinois who were enrolled in the Knight Alzheimer’s Disease Research Center. Data were collected from August 28, 2012, to March 14, 2023, and analyzed from April 1 to 25, 2023. Participants with healthy cognition, defined as a Clinical Dementia Rating score of 0 at baseline and subsequent visits, who had available clinical, neuropsychological, road tests, and self-reported medication data were included. Exposure Potentially driver-impairing medication use. Main Outcomes and Measures The primary outcome measure was performance on the Washington University Road Test (pass or marginal/fail). Multivariable Cox proportional hazards models were used to evaluate associations between potentially driver-impairing medication use and road test performance.

Results

Of the 198 included adults (mean [SD] baseline age, 72.6 [4.6] years; 87 female [43.9%]), 70 (35%) received a marginal/fail rating on the road test over a mean (SD) follow-up of 5.70 (2.45) years. Any use of antidepressants (adjusted hazard ratio [aHR], 2.68; 95% CI, 1.69-4.71), serotonin and norepinephrine reuptake inhibitors (aHR, 2.68; 95% CI, 1.54-4.64), sedatives or hypnotics (aHR, 2.70; 95% CI, 1.40-5.19), or nonsteroidal anti-inflammatory drugs (aHR, 2.72; 95% CI, 1.31-5.63) was associated with an increase in risk of receiving a marginal/fail rating on the road test compared with control individuals. Conversely, participants taking lipid-lowering agents had a lower risk of receiving a marginal/fail rating compared to control individuals. There were no statistically significant associations found between anticholinergic or antihistamines and poor performance. Conclusions and Relevance In this prospective cohort study, specific medication classes were associated with an increase in risk of poor road test performance over time. Clinicians should consider this information and counsel patients accordingly when prescribing these medications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antidepressive AgentsCholinergic AntagonistsHumansFemaleAgedProspective StudiesHypnotics and SedativesHistamine AntagonistsAnti-Inflammatory Agents

Substanzen

Antidepressive AgentsCholinergic AntagonistsHypnotics and SedativesHistamine AntagonistsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Medicine, Washington University in St Louis, St Louis, Missouri.
  • Department of Neurology, Washington University in Saint Louis School of Medicine, St Louis, Missouri.
  • Department of Pharmaceutical and Administrative Sciences, University of Health Sciences and Pharmacy in St Louis, St Louis, Missouri.
  • Center for Clinical Studies, Washington University School of Medicine, St Louis, Missouri.
  • Institute of Public Health, Washington University School of Medicine, St Louis, Missouri.
  • Department of Psychology, Faculty of Humanities, University of Johannesburg, Johannesburg, South Africa.

Förderung

  • NIA NIH HHS

Zitieren

APA

Carr, D. B., Beyene, K., Doherty, J., Murphy, S. A., Johnson, A. M., Domash, H., Riley, N., Walker, A., Sabapathy, A., Morris, J. C., & Babulal, G. M. (2023). Medication and Road Test Performance Among Cognitively Healthy Older Adults. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2023.35651

Vancouver

Carr DB, Beyene K, Doherty J, Murphy SA, Johnson AM, Domash H, et al. Medication and Road Test Performance Among Cognitively Healthy Older Adults. JAMA Network Open. 2023. doi:10.1001/jamanetworkopen.2023.35651

BibTeX
@article{Carr2023,
  author = {Carr, David B and Beyene, Kebede and Doherty, Jason and Murphy, Samantha A and Johnson, Ann M and Domash, Hailee and Riley, Noah and Walker, Alexis and Sabapathy, Ashwin and Morris, John C and Babulal, Ganesh M},
  title = {Medication and Road Test Performance Among Cognitively Healthy Older Adults},
  journal = {JAMA Network Open},
  year = {2023},
  doi = {10.1001/jamanetworkopen.2023.35651}
}
Kostenlos starten →